Neoantigen Vaccines Pass the Immunogenicity Test.
Trends Mol Med
; 23(10): 869-871, 2017 10.
Article
em En
| MEDLINE
| ID: mdl-28867556
ABSTRACT
Neoantigens arising from tumor-specific genomic alterations constitute authentic non-self antigens and represent a new class of targets for cancer immunotherapy. Recent reports on various vaccine platforms targeting neoantigens suggest a basis for precision therapies customized to each patient's tumor mutational profile.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinas Anticâncer
/
Imunogenicidade da Vacina
/
Imunoterapia
/
Antígenos de Neoplasias
/
Neoplasias
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Trends Mol Med
Ano de publicação:
2017
Tipo de documento:
Article